500 - Iran’s Baddie Era & The Data Center Destiny

“

She's believed to favor an EU wide ban on access for youth up to age 16.

Terry Schultz

NPR News: 07-13-2026 1AM EDT

♥ 0

“

The commission chief has expressed her personal concerns blaming social media's business models for treating children's attention as a commodity and exploiting addictive design.

Terry Schultz

NPR News: 07-13-2026 1AM EDT

♥ 0

“

The scary open secret in the AI industry right now is that it's possible that we'll end up essentially creating a new species that ends up ruling the world with a 70% chance that this goes horribly wrong like human extinction.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

Anthropic and OpenAI in particular are trying to automate themselves. Like they're trying to make it the case that they don't really need human employees anymore.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

I think it would be more accurate to describe it as army of geniuses in the data center because it's not like it's a bunch of diverse different AIs. They're all copies of the same big model, and they're owned by the company.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

It's kind of just like obviously a dangerous thing to be doing. But we're doing it anyway because of this history of how the field has developed in the last ten years.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

I think I would not press the button, but I feel very torn about it.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

I think if it was a sort of temporary shutdown, I would totally slam that button. Because we are not ready to do this. Civilization is not ready to have these companies automate themselves.

Daniel Kokotajlo

OpenAI Whistleblower FINALLY Speaks: “A…

♥ 0

“

I think for preventing Alzheimer's disease, what's going to have the biggest impact is AI for early detection of changes in our patterns of thinking, in addition to a cocktail of medications designed to ameliorate first inflammation and then pathology in the high risk group patients.

Gayatri Devi

#399 ‒ The evolution of Alzheimer's dis…

♥ 0